nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—ABCB11—bile canaliculus—sclerosing cholangitis	0.236	0.295	CbGeAlD
Tamoxifen—ABCC2—bile canaliculus—sclerosing cholangitis	0.12	0.15	CbGeAlD
Tamoxifen—FMO3—sweat—sclerosing cholangitis	0.107	0.134	CbGeAlD
Tamoxifen—ABCB11—bile duct—sclerosing cholangitis	0.0737	0.092	CbGeAlD
Tamoxifen—ABCB11—bile—sclerosing cholangitis	0.0567	0.0707	CbGeAlD
Tamoxifen—ABCC2—bile duct—sclerosing cholangitis	0.0375	0.0468	CbGeAlD
Tamoxifen—ABCC2—bile—sclerosing cholangitis	0.0288	0.036	CbGeAlD
Tamoxifen—ABCB11—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.0153	0.0769	CbGpPWpGaD
Tamoxifen—CES1—gall bladder—sclerosing cholangitis	0.0123	0.0153	CbGeAlD
Tamoxifen—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00958	0.0483	CbGpPWpGaD
Tamoxifen—EBPL—liver—sclerosing cholangitis	0.00934	0.0117	CbGeAlD
Tamoxifen—EBP—liver—sclerosing cholangitis	0.00895	0.0112	CbGeAlD
Tamoxifen—ABCC2—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0087	0.0438	CbGpPWpGaD
Tamoxifen—DHCR7—pancreas—sclerosing cholangitis	0.00829	0.0103	CbGeAlD
Tamoxifen—ESRRA—pancreas—sclerosing cholangitis	0.00816	0.0102	CbGeAlD
Tamoxifen—ESRRA—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.00789	0.0397	CbGpPWpGaD
Tamoxifen—ESRRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.00772	0.0389	CbGpPWpGaD
Tamoxifen—SULT1A1—liver—sclerosing cholangitis	0.00742	0.00926	CbGeAlD
Tamoxifen—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00728	0.0367	CbGpPWpGaD
Tamoxifen—UGT1A4—liver—sclerosing cholangitis	0.00647	0.00808	CbGeAlD
Tamoxifen—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.00532	0.0268	CbGpPWpGaD
Tamoxifen—DHCR7—liver—sclerosing cholangitis	0.00528	0.00658	CbGeAlD
Tamoxifen—FMO1—liver—sclerosing cholangitis	0.00528	0.00658	CbGeAlD
Tamoxifen—ESRRA—liver—sclerosing cholangitis	0.00519	0.00648	CbGeAlD
Tamoxifen—SULT1A1—Phase II conjugation—GGT1—sclerosing cholangitis	0.00501	0.0252	CbGpPWpGaD
Tamoxifen—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00464	0.0234	CbGpPWpGaD
Tamoxifen—ABCB11—liver—sclerosing cholangitis	0.00461	0.00575	CbGeAlD
Tamoxifen—FMO3—liver—sclerosing cholangitis	0.00456	0.00569	CbGeAlD
Tamoxifen—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00455	0.0229	CbGpPWpGaD
Tamoxifen—CYP3A7—liver—sclerosing cholangitis	0.00451	0.00563	CbGeAlD
Tamoxifen—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00409	0.0206	CbGpPWpGaD
Tamoxifen—CYP3A7-CYP3A51P—liver—sclerosing cholangitis	0.00384	0.00479	CbGeAlD
Tamoxifen—SIGMAR1—pancreas—sclerosing cholangitis	0.0038	0.00474	CbGeAlD
Tamoxifen—CES1—liver—sclerosing cholangitis	0.0036	0.00449	CbGeAlD
Tamoxifen—ESR2—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00343	0.0173	CbGpPWpGaD
Tamoxifen—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00342	0.0172	CbGpPWpGaD
Tamoxifen—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00336	0.0169	CbGpPWpGaD
Tamoxifen—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0032	0.0161	CbGpPWpGaD
Tamoxifen—CYP2A6—liver—sclerosing cholangitis	0.00313	0.00391	CbGeAlD
Tamoxifen—ESR2—liver—sclerosing cholangitis	0.00312	0.00389	CbGeAlD
Tamoxifen—CYP3A5—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00296	0.0149	CbGpPWpGaD
Tamoxifen—SULT1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.00293	0.0147	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00279	0.0141	CbGpPWpGaD
Tamoxifen—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00273	0.0138	CbGpPWpGaD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00265	0.0133	CbGpPWpGaD
Tamoxifen—CYP3A5—pancreas—sclerosing cholangitis	0.00249	0.00311	CbGeAlD
Tamoxifen—UGT1A4—Phase II conjugation—GGT1—sclerosing cholangitis	0.00249	0.0125	CbGpPWpGaD
Tamoxifen—CYP19A1—liver—sclerosing cholangitis	0.00246	0.00307	CbGeAlD
Tamoxifen—ESR1—AP-1 transcription factor network—BCL2L11—sclerosing cholangitis	0.00244	0.0123	CbGpPWpGaD
Tamoxifen—FMO1—Biological oxidations—GGT1—sclerosing cholangitis	0.00243	0.0122	CbGpPWpGaD
Tamoxifen—SIGMAR1—liver—sclerosing cholangitis	0.00242	0.00301	CbGeAlD
Tamoxifen—ABCC2—liver—sclerosing cholangitis	0.00235	0.00293	CbGeAlD
Tamoxifen—CYP1B1—liver—sclerosing cholangitis	0.0023	0.00287	CbGeAlD
Tamoxifen—ESR1—liver—sclerosing cholangitis	0.00214	0.00266	CbGeAlD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00212	0.0107	CbGpPWpGaD
Tamoxifen—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00211	0.0106	CbGpPWpGaD
Tamoxifen—CYP1B1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.0021	0.0106	CbGpPWpGaD
Tamoxifen—CES1—NRF2 pathway—GGT1—sclerosing cholangitis	0.00204	0.0103	CbGpPWpGaD
Tamoxifen—CYP2C19—liver—sclerosing cholangitis	0.00202	0.00251	CbGeAlD
Tamoxifen—CYP1A2—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00179	0.00899	CbGpPWpGaD
Tamoxifen—CYP2C8—liver—sclerosing cholangitis	0.00176	0.00219	CbGeAlD
Tamoxifen—FMO3—Biological oxidations—GGT1—sclerosing cholangitis	0.00174	0.00876	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00173	0.00872	CbGpPWpGaD
Tamoxifen—ABCG2—liver—sclerosing cholangitis	0.00171	0.00213	CbGeAlD
Tamoxifen—CYP1A1—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.00168	0.00844	CbGpPWpGaD
Tamoxifen—UGT1A4—NRF2 pathway—GGT1—sclerosing cholangitis	0.00166	0.00837	CbGpPWpGaD
Tamoxifen—CYP1A2—liver—sclerosing cholangitis	0.00165	0.00205	CbGeAlD
Tamoxifen—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.00164	0.00827	CbGpPWpGaD
Tamoxifen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.00164	0.00826	CbGpPWpGaD
Tamoxifen—CYP1A1—liver—sclerosing cholangitis	0.00162	0.00203	CbGeAlD
Tamoxifen—CYP3A5—liver—sclerosing cholangitis	0.00159	0.00198	CbGeAlD
Tamoxifen—CYP2B6—liver—sclerosing cholangitis	0.00158	0.00197	CbGeAlD
Tamoxifen—CYP2C9—liver—sclerosing cholangitis	0.00156	0.00195	CbGeAlD
Tamoxifen—CYP2E1—liver—sclerosing cholangitis	0.00148	0.00185	CbGeAlD
Tamoxifen—UGT1A4—Biological oxidations—GGT1—sclerosing cholangitis	0.00146	0.00734	CbGpPWpGaD
Tamoxifen—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00138	0.00694	CbGpPWpGaD
Tamoxifen—ABCB1—pancreas—sclerosing cholangitis	0.00133	0.00165	CbGeAlD
Tamoxifen—FMO3—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00131	0.00659	CbGpPWpGaD
Tamoxifen—CYP1A1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00129	0.0065	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—ABCB4—sclerosing cholangitis	0.00124	0.00627	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—ABCB4—sclerosing cholangitis	0.00122	0.00615	CbGpPWpGaD
Tamoxifen—CYP3A4—liver—sclerosing cholangitis	0.00119	0.00149	CbGeAlD
Tamoxifen—CYP2C8—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00118	0.00596	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—ABCB4—sclerosing cholangitis	0.00118	0.00594	CbGpPWpGaD
Tamoxifen—CYP2D6—liver—sclerosing cholangitis	0.00117	0.00146	CbGeAlD
Tamoxifen—DHCR7—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00115	0.00577	CbGpPWpGaD
Tamoxifen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.00113	0.00569	CbGpPWpGaD
Tamoxifen—EBP—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00109	0.00547	CbGpPWpGaD
Tamoxifen—ESR2—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00108	0.00545	CbGpPWpGaD
Tamoxifen—ESR1—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00108	0.00544	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00106	0.00535	CbGpPWpGaD
Tamoxifen—CYP2C19—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00106	0.00532	CbGpPWpGaD
Tamoxifen—ESR1—AP-1 transcription factor network—HIF1A—sclerosing cholangitis	0.00104	0.00522	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—ABCB4—sclerosing cholangitis	0.00101	0.00511	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00101	0.00507	CbGpPWpGaD
Tamoxifen—ABCG2—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.000967	0.00487	CbGpPWpGaD
Tamoxifen—CYP2C9—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.000964	0.00485	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—ABCB4—sclerosing cholangitis	0.000943	0.00475	CbGpPWpGaD
Tamoxifen—ABCC2—NRF2 pathway—GGT1—sclerosing cholangitis	0.000931	0.00469	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.000916	0.00461	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000909	0.00458	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000868	0.00437	CbGpPWpGaD
Tamoxifen—ABCB1—liver—sclerosing cholangitis	0.000843	0.00105	CbGeAlD
Tamoxifen—CYP1A2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.000824	0.00415	CbGpPWpGaD
Tamoxifen—CYP19A1—Biological oxidations—GGT1—sclerosing cholangitis	0.000811	0.00408	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000791	0.00398	CbGpPWpGaD
Tamoxifen—CYP1B1—Biological oxidations—GGT1—sclerosing cholangitis	0.000781	0.00393	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000759	0.00382	CbGpPWpGaD
Tamoxifen—CYP2A6—NRF2 pathway—GGT1—sclerosing cholangitis	0.000736	0.0037	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000731	0.00368	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ABCB4—sclerosing cholangitis	0.000725	0.00365	CbGpPWpGaD
Tamoxifen—CYP3A7—Biological oxidations—GGT1—sclerosing cholangitis	0.000704	0.00354	CbGpPWpGaD
Tamoxifen—CYP2A6—Biological oxidations—GGT1—sclerosing cholangitis	0.000645	0.00325	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ABCB4—sclerosing cholangitis	0.000608	0.00306	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—GOT2—sclerosing cholangitis	0.000591	0.00298	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—GOT2—sclerosing cholangitis	0.00058	0.00292	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.000575	0.00289	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—GOT2—sclerosing cholangitis	0.00056	0.00282	CbGpPWpGaD
Tamoxifen—CYP1A2—Phase II conjugation—GGT1—sclerosing cholangitis	0.000524	0.00264	CbGpPWpGaD
Tamoxifen—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.000523	0.00263	CbGpPWpGaD
Tamoxifen—CYP2B6—Biological oxidations—GGT1—sclerosing cholangitis	0.000521	0.00262	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—GGT1—sclerosing cholangitis	0.00051	0.00257	CbGpPWpGaD
Tamoxifen—DHCR7—Metabolism—GOT1—sclerosing cholangitis	0.00051	0.00257	CbGpPWpGaD
Tamoxifen—CYP2E1—Biological oxidations—GGT1—sclerosing cholangitis	0.00051	0.00257	CbGpPWpGaD
Tamoxifen—CYP3A5—Biological oxidations—GGT1—sclerosing cholangitis	0.000509	0.00256	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—GOT1—sclerosing cholangitis	0.000501	0.00252	CbGpPWpGaD
Tamoxifen—SULT1A1—Metabolism—GGT1—sclerosing cholangitis	0.000501	0.00252	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—GGT1—sclerosing cholangitis	0.000484	0.00244	CbGpPWpGaD
Tamoxifen—EBP—Metabolism—GOT1—sclerosing cholangitis	0.000484	0.00244	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—GOT2—sclerosing cholangitis	0.000482	0.00243	CbGpPWpGaD
Tamoxifen—CYP1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.000481	0.00242	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00045	0.00227	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—GOT2—sclerosing cholangitis	0.000448	0.00226	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ABCB4—sclerosing cholangitis	0.000448	0.00226	CbGpPWpGaD
Tamoxifen—CYP2C8—Biological oxidations—GGT1—sclerosing cholangitis	0.000441	0.00222	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000428	0.00215	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—GOT1—sclerosing cholangitis	0.000416	0.00209	CbGpPWpGaD
Tamoxifen—FMO1—Metabolism—GGT1—sclerosing cholangitis	0.000416	0.00209	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000413	0.00208	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000413	0.00208	CbGpPWpGaD
Tamoxifen—CYP2C19—Biological oxidations—GGT1—sclerosing cholangitis	0.000393	0.00198	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—GOT1—sclerosing cholangitis	0.000387	0.00195	CbGpPWpGaD
Tamoxifen—ESRRA—Metabolism—GGT1—sclerosing cholangitis	0.000387	0.00195	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000368	0.00185	CbGpPWpGaD
Tamoxifen—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	0.000362	0.00182	CbGpPWpGaD
Tamoxifen—CYP2C9—Biological oxidations—GGT1—sclerosing cholangitis	0.000359	0.00181	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GOT2—sclerosing cholangitis	0.000345	0.00173	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ABCB4—sclerosing cholangitis	0.000338	0.0017	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000336	0.00169	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ABCB4—sclerosing cholangitis	0.000326	0.00164	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000311	0.00157	CbGpPWpGaD
Tamoxifen—CYP1A2—Biological oxidations—GGT1—sclerosing cholangitis	0.000307	0.00154	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.0003	0.00151	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GGT1—sclerosing cholangitis	0.000297	0.0015	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—GOT1—sclerosing cholangitis	0.000297	0.0015	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ABCB4—sclerosing cholangitis	0.000296	0.00149	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ABCB4—sclerosing cholangitis	0.000294	0.00148	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GOT2—sclerosing cholangitis	0.000289	0.00145	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000287	0.00145	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ABCB4—sclerosing cholangitis	0.000269	0.00135	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GGT1—sclerosing cholangitis	0.000249	0.00125	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—GOT1—sclerosing cholangitis	0.000249	0.00125	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.000237	0.00119	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ABCB4—sclerosing cholangitis	0.000217	0.00109	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GOT2—sclerosing cholangitis	0.000213	0.00107	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ABCB4—sclerosing cholangitis	0.000213	0.00107	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ABCB4—sclerosing cholangitis	0.000212	0.00107	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ABCB4—sclerosing cholangitis	0.0002	0.00101	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000185	0.00093	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ABCB4—sclerosing cholangitis	0.000184	0.000925	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GGT1—sclerosing cholangitis	0.000184	0.000925	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GOT1—sclerosing cholangitis	0.000184	0.000925	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00017	0.000855	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000169	0.000852	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ABCB4—sclerosing cholangitis	0.000164	0.000826	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GOT2—sclerosing cholangitis	0.000161	0.000809	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.00016	0.000806	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GOT2—sclerosing cholangitis	0.000155	0.000779	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000151	0.000761	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	0.000151	0.00076	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ABCB4—sclerosing cholangitis	0.00015	0.000753	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GOT2—sclerosing cholangitis	0.000141	0.000708	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GOT2—sclerosing cholangitis	0.000139	0.000702	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GGT1—sclerosing cholangitis	0.000139	0.000698	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GOT1—sclerosing cholangitis	0.000139	0.000698	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000138	0.000694	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GOT1—sclerosing cholangitis	0.000133	0.000672	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GGT1—sclerosing cholangitis	0.000133	0.000672	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GOT2—sclerosing cholangitis	0.000128	0.000644	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ABCB4—sclerosing cholangitis	0.000128	0.000644	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GGT1—sclerosing cholangitis	0.000121	0.000612	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GOT1—sclerosing cholangitis	0.000121	0.000612	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GGT1—sclerosing cholangitis	0.00012	0.000606	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GOT1—sclerosing cholangitis	0.00012	0.000606	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000118	0.000593	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GGT1—sclerosing cholangitis	0.00011	0.000556	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GOT1—sclerosing cholangitis	0.00011	0.000556	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GOT2—sclerosing cholangitis	0.000103	0.000519	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GOT2—sclerosing cholangitis	0.000101	0.000509	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GOT2—sclerosing cholangitis	0.000101	0.000508	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	9.86e-05	0.000497	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GOT2—sclerosing cholangitis	9.52e-05	0.00048	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GGT1—sclerosing cholangitis	8.9e-05	0.000448	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GOT1—sclerosing cholangitis	8.9e-05	0.000448	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GOT2—sclerosing cholangitis	8.73e-05	0.00044	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GOT1—sclerosing cholangitis	8.72e-05	0.000439	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GGT1—sclerosing cholangitis	8.72e-05	0.000439	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GGT1—sclerosing cholangitis	8.7e-05	0.000438	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GOT1—sclerosing cholangitis	8.7e-05	0.000438	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GGT1—sclerosing cholangitis	8.22e-05	0.000414	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GOT1—sclerosing cholangitis	8.22e-05	0.000414	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GOT2—sclerosing cholangitis	7.79e-05	0.000392	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GOT2—sclerosing cholangitis	7.61e-05	0.000383	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GGT1—sclerosing cholangitis	7.54e-05	0.00038	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GOT1—sclerosing cholangitis	7.54e-05	0.00038	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HIF1A—sclerosing cholangitis	7.22e-05	0.000364	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	7.17e-05	0.000361	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GOT2—sclerosing cholangitis	7.11e-05	0.000358	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GOT1—sclerosing cholangitis	6.73e-05	0.000339	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GGT1—sclerosing cholangitis	6.73e-05	0.000339	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GGT1—sclerosing cholangitis	6.57e-05	0.000331	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GOT1—sclerosing cholangitis	6.57e-05	0.000331	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	6.19e-05	0.000312	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	6.19e-05	0.000312	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GGT1—sclerosing cholangitis	6.13e-05	0.000309	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GOT1—sclerosing cholangitis	6.13e-05	0.000309	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GOT2—sclerosing cholangitis	6.07e-05	0.000306	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GOT1—sclerosing cholangitis	5.24e-05	0.000264	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GGT1—sclerosing cholangitis	5.24e-05	0.000264	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	4.69e-05	0.000236	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	4.05e-05	0.000204	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	4.05e-05	0.000204	CbGpPWpGaD
